JW Therapeutics opens $300m Hong Kong IPO
JW (Cayman) Therapeutics set its IPO in motion on Thursday, opening the order book for the up to HK$2.3bn ($300m) deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: